Jennifer Horne, PA
Physician Assistant · Springfield, MANPI 1174191571
Payments from drug & device makers
Across 183 payments — averaging $22.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$551
- Novartis$538
- Bridgebio Pharma, Inc.$361
- Alnylam Pharmaceuticals Inc.$323
- AstraZeneca$252
- Boehringer Ingelheim$185
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,069100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 29 | $551 |
| Novartis | 21 | $538 |
| Bridgebio Pharma, Inc. | 16 | $361 |
| Alnylam Pharmaceuticals Inc. | 13 | $323 |
| AstraZeneca | 14 | $252 |
| Boehringer Ingelheim | 9 | $185 |
| Novo Nordisk | 7 | $168 |
| Actelion Pharmaceuticals US, Inc. | 6 | $158 |
| Amgen | 8 | $145 |
| Abiomed | 4 | $130 |
| Endo Pharmaceuticals Inc. | 7 | $120 |
| Johnson & Johnson | 4 | $120 |
| Bayer | 5 | $112 |
| Edwards Lifesciences | 3 | $89 |
| E.r. Squibb & Sons, L.L.C. | 4 | $84 |
| Urovant Sciences Inc | 4 | $75 |
| Merck | 3 | $67 |
| Coloplast | 3 | $66 |
| Harmony Biosciences LLC | 2 | $58 |
| Antares Pharma, Inc. | 2 | $52 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $45 |
| Lilly USA, LLC | 2 | $41 |
| Altathera Pharmaceuticals LLC | 1 | $35 |
| Heartflow, Inc. | 1 | $34 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Boston Scientific | 1 | $27 |
| Lantheus Medical Imaging, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Axonics, Inc. | 1 | $23 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $20 |
| GSK | 1 | $19 |
| Myovant Sciences Inc. | 1 | $17 |
| Procept Biorobotics Corporation | 1 | $16 |
| Tolmar, Inc. | 1 | $16 |
How this compares
$4,069 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 45 | $61,881 |
| EntrestoSacubitril/Valsartan | 17 | $20,170 |
| FarxigaDapagliflozin Propanediol | 17 | $16,381 |
| GemtesaVibegron | 23 | $12,371 |
| Tamsulosin Hcl | 123 | $2,332 |
| Metoprolol Succinate | 66 | $1,114 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 17 | $1,084 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 27 | $1,003 |
| Methenamine Hippurate | 12 | $801 |
| Finasteride | 53 | $748 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $696 |
| Atorvastatin Calcium | 39 | $592 |
| Amlodipine Besylate | 57 | $380 |
| Rosuvastatin Calcium | 16 | $379 |
| Flecainide Acetate | 12 | $337 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $551 | $61,88145 claims |
| NovartisEntresto | $538 | $20,17017 claims |
| AstraZenecaFarxiga | $252 | $16,38117 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $27 | $12,37123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,507 physician assistant providers in Massachusetts.
Other physician assistant in Springfield
- Stacey PanasciSpringfield$113K
- Leslie SmithSpringfield$49K
- Kerri St GeorgeSpringfield$18K
- Cassandra AyreSpringfield$15K
- Marianne LangloisSpringfield$9K
- Christopher MasseyWilbraham$190K
- Lizabeth O ConnorEverett$182K
- Kimberly ComeauSwampscott$120K
- Jason RandWaltham$99K
- Karen ChunEast Boston$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.